Tesamorelin 10mg
Research-grade Tesamorelin 10mg. 99% purity, third-party tested with published COA.
Ships from USA
1–3 day delivery
Free Shipping
On orders $150+
Third-Party Lab Tested
99.10%
HPLC Purity
13.91 mg
Batch #2603300139
Purity Method
HPLC Tested
Identity
Mass Spec (MS)
Peptide Handling & Storage Guide
Storage temperature, shelf life & reconstitution (PDF)
99%+ Purity
COA included
Same-Day Shipping
Orders before 2PM EST
Secure Checkout
SSL encrypted
Shipment Protection
Lost or damaged — reshipped free
Compound Information
- Type
- GHRH analog — human GHRH(1-44) with N-terminal acyl
- Molecular Formula
- C221H366N72O67S
- Molecular Weight
- 5135.9 g/mol
- CAS Number
- 218949-48-5
- Purity
- 99%
- Sequence
- trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
- Also known as
- TH9507
Reference chemistry (free base) from public chemical databases and peer-reviewed literature. For laboratory research identification only.
Research Use Only. This vial is bound for the lab bench — supplied for in-vitro scientific work exclusively, never for administration to any person or animal.
About Tesamorelin
Tesamorelin (developmental code TH9507) is a stabilized synthetic analog of human growth-hormone-releasing hormone: it reproduces the full 44-amino-acid sequence of human GHRH (GHRH 1-44) and carries a hexenoyl group on its N-terminal tyrosine, a modification associated with greater resistance to enzymatic breakdown. Pharmacologically it is a GHRH-receptor (GRF-receptor) agonist — it stimulates pituitary somatotroph cells to synthesize and release endogenous growth hormone in a pulsatile manner, whose downstream effects are mediated largely by liver-derived IGF-1.
The molecule is distinguished from native GHRH by that N-terminal hexenoyl modification, which is the basis of its stability in laboratory preparations, and by being the full 44-residue sequence rather than a truncated fragment such as GHRH 1-29 (sermorelin). It is one of several structurally distinct compounds used as reagents in growth-hormone-axis research, alongside the ghrelin-receptor secretagogues. The material supplied here is a research chemical for in vitro and laboratory use. It is not an approved drug product and is not for human or veterinary use.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic analog of human growth-hormone-releasing hormone (GHRH) that acts as a GHRH-receptor agonist. It reproduces the 44-amino-acid human GHRH sequence with a stabilizing N-terminal modification. It is supplied here strictly for laboratory research use and is not for human or veterinary use.
What is the difference between Tesamorelin and Ipamorelin?
They act through different receptors. Tesamorelin is a GHRH analog that stimulates the GHRH receptor; ipamorelin acts instead at the ghrelin / growth-hormone-secretagogue receptor. Both are studied in relation to growth-hormone release but through separate pathways, which is why they are sometimes examined alongside one another in laboratory work. Both are provided here for research use only.
What is the difference between Tesamorelin and Sermorelin?
Both are GHRH-receptor agonists, but they are different lengths. Tesamorelin reproduces the full 44-residue GHRH sequence with a stabilizing N-terminal hexenoyl group; sermorelin corresponds to GHRH 1-29, the shorter N-terminal fragment that retains receptor activity. Both are supplied for laboratory research use only.
Is Tesamorelin an approved drug?
The material supplied here is not. It is a research chemical intended for in vitro and laboratory use, it is not a pharmaceutical product, and it is not for human or veterinary use.
Research & References
Independent databases and peer-reviewed literature for Tesamorelin. Provided for research reference only.
External resources are independent and not affiliated with or endorsed by PHIOGEN. Listed for laboratory research reference only.
